Teemu Haikarainen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Induced Apoptosis

Tyrosine Kinase

Structural Basis

Top Venues

Journal of medicinal chemistry

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Bobin George Abraham, Teemu Haikarainen, Joni Vuorio, Mykhailo Girych, Anniina T Virtanen, Antti Kurttila, Christos Karathanasis, Mike Heilemann, Vivek Sharma, Ilpo Vattulainen, Olli Silvennoinen
Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling. Science advances 10 (10) (2024)
Ya Miao, Anniina Virtanen, Jakub Zmajkovic, Morgane Hilpert, Radek C Skoda, Olli Silvennoinen, Teemu Haikarainen
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. Journal of medicinal chemistry 67 (12) (2024)
Ya Miao, Anniina Virtanen, Jakub Zmajkovic, Morgane Hilpert, Radek C Skoda, Olli Silvennoinen, Teemu Haikarainen
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. Journal of medicinal chemistry 67 (12) (2024)
Ya Miao, Anniina Virtanen, Jakub Zmajkovic, Morgane Hilpert, Radek C Skoda, Olli Silvennoinen, Teemu Haikarainen
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. Journal of medicinal chemistry 67 (12) (2024)
Bobin George Abraham, Teemu Haikarainen, Joni Vuorio, Mykhailo Girych, Anniina T Virtanen, Antti Kurttila, Christos Karathanasis, Mike Heilemann, Vivek Sharma, Ilpo Vattulainen, Olli Silvennoinen
Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling. Science advances 10 (10) (2024)
Bobin George Abraham, Teemu Haikarainen, Joni Vuorio, Mykhailo Girych, Anniina T Virtanen, Antti Kurttila, Christos Karathanasis, Mike Heilemann, Vivek Sharma, Ilpo Vattulainen, Olli Silvennoinen
Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling. Science advances 10 (10) (2024)
Ya Miao, Anniina Virtanen, Jakub Zmajkovic, Morgane Hilpert, Radek C Skoda, Olli Silvennoinen, Teemu Haikarainen
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. Journal of medicinal chemistry 67 (12) (2024)
Ya Miao, Anniina Virtanen, Jakub Zmajkovic, Morgane Hilpert, Radek C Skoda, Olli Silvennoinen, Teemu Haikarainen
Functional and Structural Characterization of Clinical-Stage Janus Kinase 2 Inhibitors Identifies Determinants for Drug Selectivity. Journal of medicinal chemistry (2024)
Bobin George Abraham, Teemu Haikarainen, Joni Vuorio, Mykhailo Girych, Anniina T Virtanen, Antti Kurttila, Christos Karathanasis, Mike Heilemann, Vivek Sharma, Ilpo Vattulainen, Olli Silvennoinen
Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling. Science advances 10 (10) (2024)